Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract
Uro-Oncology
Related content
Further Publications Urology
Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice
J Urol
Merseburger AS, Castellano D, Powles T, Loriot Y, Retz M, Voortman J, Huddart RA, Gedye C, Van Der Heijden MS, Gurney H, Ong M, de Ducla S, Pavlova J, Fear S, Sternberg CN
doi: 10.1097/JU.0000000000001768
Overactive Bladder
Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial
Eur Urol
van der Heijden MS, Loriot Y, Durán I, Ravaud A, Retz M, Vogelzang NJ, Nelson B, Wang J, Shen X, Powles T
doi: 10.1016/j.eururo.2021.03.024
Overactive Bladder
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
Eur Urol.
Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Gontero P, Van Rhijn BWG, Mostafid AH, Palou J, Shariat SF
doi: 10.1016/j.eururo.2017.07.036.
Lower Urinary Tract Symptoms
Efficacy and Safety of Desmopressin Add-On Therapy for Men with Persistent Nocturia on α-Blocker Monotherapy for Lower Urinary Tract Symptoms: A Randomized, Double-Blind, Placebo Controlled Study.
J Urol.
Kim JC, Cho KJ, Lee JG, Seo JT, Kim DY, Oh SJ, Lee KS, Choo MS, Lee JZ
doi: 10.1016/j.juro.2016.08.116.
Lower Urinary Tract SymptomsOveractive BladderUro-Oncology
The role of urinary cytology when diagnostic workup is suspicious for upper tract urothelial carcinoma but tumour biopsy is nonconfirmatory
Can Urol Assoc J.
Horovitz D, Meng Y, Joseph JV, Feng C, Wu G, Rashid H, Messing EM
doi: 10.5489/cuaj.4150.
Overactive Bladder
Conservative treatment of upper urinary tract carcinoma: Long-term results
Can Urol Assoc J.
Andrada AO, García IL, Fúnez FA, Canet FD, Ruiz GD, Dos Santos VG, Revilla FJB
doi: 10.5489/cuaj.4173.
COMMENTED
Uro-Oncology
Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
doi: 10.1016/j.eururo.2020.01.033.
Uro-Oncology
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update
Eur Urol.
Rouprêt M, Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Cowan NC, Dominguez-Escrig JL, Gontero P, Hugh Mostafid A, Palou J, Peyronnet B, Seisen T, Soukup V, Sylvester RJ, Rhijn BWGV, Zigeuner R, Shariat SF
doi: 10.1016/j.eururo.2020.05.042.
Overactive BladderUrinary IncontinenceUrinary Tract Infections (UTI)
Bladder emptying method is the primary determinant of urinary tract infections in patients with spinal cord injury: results from a prospective rehabilitation cohort study
BJU Int.
Anderson CE, Chamberlain JD, Jordan X, Kessler TM, Luca E, Möhr S, Pannek J, Schubert M, Brinkhof MWG; SwiSCI Study Group
doi: 10.1111/bju.14514.